🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

An impassioned talk by the eloquent Sagar Lonial MD about how to get to CURE using available immunotherapies

So many things to be grateful for but most thankful this year for my lil turkey! Happy Thanksgiving to all

Applaud the massive effort Mike Thompson, MD, PhD, FASCO undertakes every year to give us a glimpse of the best of #mmsm at ASH and grateful to be included on this list!

Glorious skies, thick crowds and ready for ASH Run

Encouraging early data showing IMiDs and possibly CelMODs can improve on the response to immunotherapy Jeffrey Matous, MD Luciano J Costa

When we presented this at EHA, less apparent but important to await data from additional patients and f/u at RP2D

Excellent thread on cilta-cel, only point I would highlight is if you progress on bridging therapy, your risk of fatal outcome 🔝 and in that situation I would not proceed directly with cilta cel but consider other options to lower disease burden!

Always great to listen to my previous co-fellow Urvi Shah talk passionately about nutrition and myeloma

Wonderful morning discussing the importance of MRD in high risk MM especially on the heels of the ODAC

Imp manuscript from the Mayo group Saurabh Zanwar showing the outcomes of pts w/ suboptimal response to DaraVCd in NDAL. I have traditionally switched to BCL2 inhibition ASAP if t(11;14) but for the rest such a tricky spot! Hopeful for TCE in this popn nature.com/articles/s4137…

Thanks Gurbakhash Kaur for the amazing kebabs delivered since she couldn’t take me out while in Dallas, the sweetest 🥹🫠

No pressure right! Debating Robert Z. Orlowski

Thank you for sharing and thanks to The Lancet Haematology for the opportunity to pen this commentary on an important update of a major practice informing - monumental study

Practical tips from Rahul Banerjee, MD, FACP #iwgprc5d2025 on managing skin and nail toxicities

The funnest talk from Joshua Richter, MD, FACP and a new acronym for neurotoxicity with gprc5d #iwgprc5d2025

Thank you for the invitation Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 and Sham Mailankody to join this fantastic meeting, really great presentations and discussion.